Centre François Baclesse

corporate_fareorganization

Centre François Baclesse

- Funding / Projects
  (49)

49 Projects, page 1 of 10

Randomized phase III study of gemcitabine and cisplatin (GC) versus high-dose-intensity methotrexate, vinblastine, doxorubicin and cisplatin (HD-MVAC) in the perioperative setting for patients with locally advanced transitional cell cancer of the bladder
assignment_turned_inProjectPartners:Centre François Baclesse, Centre Léon Bérard, Institut Bergonié, Hôpital Saint-Louis, Institut Curie +6 partners
Centre François Baclesse,
Centre Léon Bérard,
Institut Bergonié,
Hôpital Saint-Louis,
Institut Curie,
Centre Hospitalier Universitaire de Rouen,
HUS,
Institut de cancérologie Lucien Neuwirth,
Institut Paoli-Calmettes- (IPC),
Institut Claudius Regaud,
Institut Gustave Roussy
Funder: Institut National du Cancer Project Code: INCa-DGOS-3712
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
Evaluation and validation of quality of life scales in palliative advance cancer Title of the study – Evaluation and validation of quality of life scales in palliative advance cancer.
assignment_turned_inProjectPartners:Centre Oscar Lambret, Centre Georges-François Leclerc, Institut Bergonié, Centre Hospitalier Universitaire d'Angers, Hôpital Jean Minjoz +7 partners
Centre Oscar Lambret,
Centre Georges-François Leclerc,
Institut Bergonié,
Centre Hospitalier Universitaire d'Angers,
Hôpital Jean Minjoz,
ICM-VAL D'AURELLE,
Centre François Baclesse,
Institut de Cancérologie de l'Ouest,
Institut Curie,
Hôpital Morvan,
Centre Antoine Lacassagne,
Centre Hospitalier de Cholet
Funder: Institut National du Cancer Project Code: INCa-DGOS-3764
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
GETUG-AFU 25/PEACE 3: Personalized treatment of patients with metastatic castrate-resistant prostate cancer (MCRPC) receiving docetaxel, using either early switch to cabazitaxel or maintenance treatment with docetaxel plus radium-223, based on circulating tumor cell (CTCs) enumeration.
assignment_turned_inProjectPartners:Centre François Baclesse, Institut Curie, Centre Eugène Marquis, Centre René Gauducheau, Institut Paoli-Calmettes- (IPC) +10 partners
Centre François Baclesse,
Institut Curie,
Centre Eugène Marquis,
Centre René Gauducheau,
Institut Paoli-Calmettes- (IPC),
Centre Hospitalier de Mont-de-Marsan,
Centre Antoine Lacassagne,
Clinique Sainte Marguerite,
Centre Léon Bérard,
Hôpital Saint-Louis,
Institut Jean Godinot,
Hôpital Saint Joseph,
Hôpital Édouard Herriot,
Institut Gustave Roussy,
Institut de Cancérologie de l'Ouest
Funder: Institut National du Cancer Project Code: INCa-DGOS-7193
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
Etude de phase III, multicentrique, randomisée avec cross-over, comparative : Doxorubicine vs ET- 743 (Yondelis) chez des patients présentant un liposarcome myxoïde métastatique.
assignment_turned_inProjectPartners:Institut Bergonié, Centre François Baclesse, Centre Henri Becquerel, Centre Oscar Lambret, CHU Marseille - Hôpital la Timone
Institut Bergonié,
Centre François Baclesse,
Centre Henri Becquerel,
Centre Oscar Lambret,
CHU Marseille - Hôpital la Timone
Funder: Institut National du Cancer Project Code: INCa-DGOS-365
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
Evaluation de la tolérance de l’association d’une radiothérapie de l’encéphale et de Bevacizumab (Avastin®) dans le traitement des métastases cérébrales
assignment_turned_inProjectPartners:Centre François Baclesse
Centre François Baclesse
Funder: Institut National du Cancer Project Code: INCa-DGOS-1169
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu

chevron_left
1
2
3
4
5
chevron_right

Centre François Baclesse

Centre François Baclesse

49 Projects, page 1 of 10

Randomized phase III study of gemcitabine and cisplatin (GC) versus high-dose-intensity methotrexate, vinblastine, doxorubicin and cisplatin (HD-MVAC) in the perioperative setting for patients with locally advanced transitional cell cancer of the bladder

Evaluation and validation of quality of life scales in palliative advance cancer Title of the study – Evaluation and validation of quality of life scales in palliative advance cancer.

GETUG-AFU 25/PEACE 3: Personalized treatment of patients with metastatic castrate-resistant prostate cancer (MCRPC) receiving docetaxel, using either early switch to cabazitaxel or maintenance treatment with docetaxel plus radium-223, based on circulating tumor cell (CTCs) enumeration.

Etude de phase III, multicentrique, randomisée avec cross-over, comparative : Doxorubicine vs ET- 743 (Yondelis) chez des patients présentant un liposarcome myxoïde métastatique.

Evaluation de la tolérance de l’association d’une radiothérapie de l’encéphale et de Bevacizumab (Avastin®) dans le traitement des métastases cérébrales

Loading